Business
VitalHub Reports Fourth Quarter and Annual 2024 Results
Annual Recurring Revenue (ARR) ⁽¹⁻²⁾ up 59% YoY to $71.1 m...
About this update from Vitalhub Corp.
[{"type":"text","content":"VitalHub Reports Fourth Quarter and Annual 2024 Results\n\n\n\n\n Annual Recurring Revenue (ARR)\n \n\n ⁽¹⁻²⁾\n \n\n up 59% YoY to $71.1 million\n \n\n\n Total Revenue up 51% YoY to $20.6 million\n \n\n\n Adjusted EBITDA\n \n\n ⁽²⁾\n \n\n up 27% YoY to $5.0 million\n \n\n\n TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) announced today it has filed its Consolidated Financial Statements and Management's Discussion and Analysis report for the year ended December 31, 2024 with the Canadian securities authorities. These documents may be viewed under the Company’s profile at\n \n www.sedarplus.com\n \n .\n \n\n “We are pleased to report strong full year results, highlighted by annual 15% organic ARR⁽¹⁻²⁾ growth and 26% adjusted EBITDA⁽²⁾ margins,” said Dan Matlow, CEO of VitalHub. “We are seeing momentum build with our growing platform functionality and reputational awareness. Our record-breaking sequential net new organic ARR⁽¹⁻²⁾ in the fourth quarter of $2.6 million was well-balanced across our leading EHR suite in Canada and patient flow solutions in the UK. We see opportunities for sustained growth rates in our core geographies as we cross-sell complementary solutions and add new clients.”\n \n\n “We closed four acquisitions in 2024, adding $17.9 million of acquisition ARR⁽¹⁻²⁾ and adding new solutions and team members that we are proud to have at VitalHub. Integration efforts from a product, infrastructure, and go-to-market perspective are well underway, including the fourth quarter 2024 acquisitions of Strata and MedCurrent. We see areas for potential enhanced revenue growth and operational efficiency, with our goal of steadily expanding our cash flow margin over the next twelve to eighteen months post-acquisition, as we have successfully accomplished historically.”\n \n\n “Our current pro forma cash balance is approximately $90 million, with strong positive cash generation and access to debt if needed. We are prepared to deploy capital on M&A, and we currently expect the pace of activity from 2024 to continue thro...